Normal growth in a patient with septo-optic dysplasia despite both growth hormone and IGF-I deficiency

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue 1, 1998, Pages 69-75

  Bereket, Abdullah ^a,d   Lang, Charles H ^b   Geffner, Mitchell E ^b   Wilson, Thomas A ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b STONY BROOK UNIVERSITY   (United States)

^c MATTEL CHILDREN S HOSPITAL   (United States)

^d NONE   (Turkey)

Author keywords

Growth hormone; Growth hormone deficiency; Growth without growth hormone; IGF I; Insulin; Septo optic dysplasia

Indexed keywords

GROWTH HORMONE; GROWTH PROMOTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BLINDNESS; CASE REPORT; CELL PROLIFERATION; CHILD GROWTH; ERYTHROID PRECURSOR CELL; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; OPTIC NERVE HYPOPLASIA; SEPTUM PELLUCIDUM;

EID: 0031911848     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1998.11.1.69     Document Type: Article

References (28)

1. Bucher H, Zapf J, Torresani T, Prader A, Froesch ER, Illig R. Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med. 1983; 309: 1142-1146.
2. Costin G, Kogut MD, Phillips SL, Daughaday WH. Craniopharyngioma: the role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 1976; 42: 370-379.
3. Ashcraft MW, Hartzband PI, Van Herle AJ, Bersch N, Golde DW. A unique growth factor in patients with acromegaloidism. J Clin Endocrinol Metab 1983; 57: 272-276.
4. Costin G, Murphree LA. Hypothalamic pituitary function in children with optic nerve hypoplasia. Am J Dis Child 1985; 139: 249-254.
5. Petrykowski WV, Blum WF, Ranke MB, Niemeyer CM. 16 years of normal growth without growth hormone (GH), without IGF-I, and IGFBP-3 and without obesity. Pediatr Res 1993; (Suppl): S62, Abstr 354.
6. Margalith D, Tze WJ, Jan JE. Congenital optic nerve hypo-plasia with hypothalamic-pituitary dysplasia. Am J Dis Child 1985; 139: 361-366.
7. Patel H, Tze WJ, Crichton JU, McCormick AQ, Robinson GC, Dolman CL. Optic nerve hypoplasia with hypopituitarism. Am J Dis Child 1975; 129: 175-180.
8. Geffner M, Lippe B, Bersch N, Kaplan S, Van Herle A, Elders MJ, Golde DW. Growth without growth hormone: evidence for a potent circulating human growth factor. Lancet 1986; 1: 343-347.
9. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RC, Wilson TA. Effect of insulin on the IGF system in children with new onset insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 1312-1317.
10. Bereket A, Wilson TA, Blethen SL, Fan J, Frost RA, Gelato MC, Lang CH. Effect of short-term fasting on free/dissociable insulin-like growth factor I concentrations in normal human serum. J Clin Endocrinol Metab 1996; 81: 4379-4384.
11. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. Insulin-like growth factor binding protein-3 proteolysis in children with insulin dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995; 80: 2282-2288.
12. Bereket A, Lang CH, Blethen SL, Wilson TA. Insulin-like growth factor binding protein-2 (IGFBP-2) and insulin: studies in children with type 1 diabetes mellitus and maturity onset diabetes of the young. J Clin Endocrinol Metab 1995; 80: 3647-3652.
13. Liu F, Hintz RL, Khare A, Diaugustine RP, Powell DR, Lee PDK. Immunoblot studies of the IGF-related acidlabile subunit. J Clin Endocrinol Metab 1994; 79: 1883-1886.
14. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd Ed. Stanford, CA: Stanford University Press, 1992; 125-183.
15. Arslanian S, Rothfus WE, Foley TP, Becker DJ. Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia. Acta Endocrinol 1984; 107: 282-288.
16. Hoyt WF, Kaplan SL, Grumbach MM, Glaser JS. Septo-optic dysplasia and pituitary dwarfism. Lancet 1970; 1: 893-894.
17. Krause-Brucker W, Gardner DW. Optic nerve hypoplasia associated with absent septum pellucidum and hypopituitarism. Am J Ophthalmol 1980; 89: 113-120.
18. Huseman CA, Kelch RP, Hopwood NJ, Zipf WB. Sexual precocity in association with septo-optic dysplasia and hypothalamic hypopituitarism. J Pediatr 1978; 92: 748-753.
19. Freude S, Frisch H, Wimberger D, Schober E, Hausler G, Waldhauser F, Aichner F. Septo-optic dysplasia and growth hormone deficiency: accelerated pubertal maturation during GH therapy Acta Paediatr 1992; 81: 641-645.
20. Sheridan SJ, Robb RM. Optic nerve hypoplasia with diabetes insipidus. Ped Ophthalmol Strab 1978; 15: 82-84.
21. Riley WJ, Rosenbloom A. Clitoral size in infancy. J Pediatr 1980; 96: 918-919.
22. Clemmons DR, Underwood LE, Ridgway EC, Kliman B, Van Wyk JJ. Hyperprolactinemia is associated with increased immunoreactive somatomedin-C in hypopituitarism. J Clin Endocrinol Metab 1981; 52: 731-735.
23. Hurley TW, D'Ercole AJ, Handwerger S, Underwood LE, Furlanetto RW, Fellows RE. Ovine placental lactogen induces somatomedin: A possible role in fetal growth. Endocrinology 1977; 101: 1635-1638.
24. Phillips LS, Goldstein S, Pao C-I. Nutrition and somatomedin. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes 1991; 40: 1525-1530.
25. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol 1991; 124: 74-85.
26. Cohick WS, Clemmons DR. The insulin-like growth factors. Ann Rev Physiol 1993. 55: 131-153.
27. Binoux M, Lalou C, Lasarre C, Blat C, Hossenlopp P. Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): a physiological mechanism in the regulation of IGF bioavailability. In: Le Roith D, Raizada MK, eds, Current Directions in Insulin-like Growth Factor Research. New York: Plenum Press, 1994; 293-300.
28. Baumann G, Mercado M. Growth hormone-binding proteins in plasma. Nutrition 1993; 9: 546-553.